Eisai Company, Ltd. (ESALY.PK) Announces Results Of Osteoporosis Fracture Study Using Menatetrenone
10/19/2005 5:12:53 PM
Tokyo (JCNN) - Eisai (TSE: 4523) has announced the results of its Osteoporosis Fracture Study (OF Study) using menatrenone. Organized by the Ministry of Health, the OF Study, which has surveyed 4,000 patients with osteoporosis since 1995, compared the two subject groups: one administered solely with calcium and the other with calcium and menatetrenone. The results show no significant difference between the two groups in terms of inhibiting effects on the occurrence of new vertebral body fracture. However, the combined administration group demonstrated decline in the shortening of body height and improvement of low back pains caused by activities of daily life (ADL).
Currently, Eisai is distributing menatetrenone under the trade name Glakay.
comments powered by